Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development ROP Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed RIVN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline KMDA Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction ICCM Q1 2026 Earnings EPS Misses Estimates as Losses Widen FRPH Q4 2024 Earnings Modest Earnings Amid Stock Decline